Skip to search.
 TSX Up 0.40% TSX Ventures Down 0.17%

Sanofi (SNY)

-NYSE
48.39 Up 0.05(0.10%) 3:19PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:48.34
Open:48.69
Bid:48.41 x 700
Ask:48.42 x 200
1y Target Est:55.00
Beta:1.15
Next Earnings Date:N/A
Day's Range:48.27 - 48.72
52wk Range:43.57 - 57.42
Volume:1,249,301
Avg Vol (3m):2,430,010
Market Cap:127.34B
P/E (ttm):26.00
EPS (ttm):1.86
Div & Yield:1.62 (3.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNYUp 0.10%127.34B
GSKDown 0.48%114.48B
MRK 0.00%164.27B
PFEDown 0.51%211.23B

Key Statistics

Forward P/E (1 yr):15.12
P/S (ttm):3.34
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est (Dec-15) :3.13
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):2.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi discovers, develops, and distributes therapeutic solutions. Its primary products include Lantus and Apidra analogs of human insulin; Insuman insulin solutions and suspensions; Amaryl, a sulfonylurea; Lyxumia, a prandial GLP-1 receptor agoni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback